wealthy

Download the Wealthy Appto enjoy efficient Trading and Investing!

Download App QR Code
google-playapp-store

Welcome to Wealthy

user
mobile
OR
google-playapp-store
Curated Investing
Curated Investing
Completely Digitalised
Completely Digitalised
Bank Grade Security
Bank Grade Security
Help Centers
Help Centers

Unbeatable brokerage with wealthy broking  

Get Started

Hot Pursuit

14 Oct '25|4:14 PM

Stallion India ends sharply higher after stellar Q2 performance

Revenues increased by 56.3% year-over-year (YoY) to Rs 105.56 crore during the quarter.

Total expenditure rose by 37.1% to Rs 89.98 crore in Q2 FY26 over Q2 FY25, primarily due to a sharp increase in raw material costs (up 71% YoY) and higher employee expenses (up 5.8x YoY).

EBITDA jumped to Rs 15.77 crore in Q2 FY26 from Rs 2.35 crore in Q2 FY25.

Profit before tax in Q2 FY26 stood at Rs 15.24 crore, which is sharply higher from Rs 0.55 crore posted in Q2 FY26.

Shazad Rustomji, managing director & CEO of Stallion India Fluorochemicals, said: 'The company delivered a strong performance during Q2 and H1 FY25-26, marked by significant growth in revenue and profitability.

Total revenue for H1 FY25-26 increased by 52.8% YoY to Rs 216.30 crore, while PAT rose sharply by 135.0% to Rs 21.78 crore. The improvement was driven by higher volumes, better product mix, and operational efficiencies across key facilities, reflecting the company's strong execution and resilient business model.

During FY 2025-26, the Company has navigated a challenging business environment characterized by cyclical slowdown, political and tariff-related headwinds, and global macroeconomic uncertainties. Notwithstanding these factors, the management had provided a revenue guidance of Rs 430 crore for FY 2025-26.'

Stallion India Fluorochemicals operates in the refrigerants and industrial gases sector. The company is engaged in processing, blending, and distributing gases across diverse industries including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production.

Powered by Capital Market - Live News